Extended use

Extended use

Any process that increases the useful life of an old building through intervention, such as restoration, renovation, or adaptive use.
Mentioned in ?
References in periodicals archive ?
Shari'ah-compliant asset purchases, such as the December 2014 $100 million joint venture between Bahrain-based Ibdar Bank and Dubai- based lessor Palma Holding with Ethiopian Airlines, are a good example of extended uses.
Though Reynolds believes ESA may have some extended uses in the plastics, and pulp and paper industry, the medical waste remains a rapidly changing field due to more heightened environmental issues and consolidation within the sector.
Other issues include extended uses for the large, open Market Place area, an examination of whether any of the three existing town centre supermarkets should be re-located and how to improve traffic flows on Waterloo Road.
Parapsychological powers are merely extended uses of powers that the mind uses normally to interact with its environment.
Group tours, school field trips, receptions and corporate events are among the many extended uses today for the Magnolia Plantation and its gardens.
Matravers sums up this position by claiming that the extended uses of terms are explained by their `clear causal links with their central use' (p.
Precision Extended uses a "list select" menu, which displays the availabl options down the center of the screen.
To date, the NCCN ORP has received nearly $40 million in research grants from pharmaceutical and biotech companies to support investigator-initiated trials including, but not limited to, evaluation of innovative regimens, mechanism of action, and exploration of extended uses for specific agents.
Studies evaluate combinations and sequencing regimens of drugs, drug resistance, and mechanisms of action of specific agents, and explore extended uses for scientific agents.
Studies evaluate combinations and sequencing regimens of drugs, drug resistance, mechanisms of action of specific agents, or explore extended uses for scientific agents.
To date, the NCCN ORP has received more than $36 million in research grants from pharmaceutical and biotech companies to support investigator- initiated trials including, but not limited to, evaluation of innovative regimens, mechanism of action, and exploration of extended uses for specific agents.

Full browser ?